<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <id>https://finance.naver.com/news/news_list.naver?mode=LSS3D&amp;section_id=101&amp;section_id2=258&amp;section_id3=406</id>
    <title>네이버 금융 ─ 뉴스 ─ 공시 메모</title>
    <updated>2021-10-29T05:06:20.947Z</updated>
    <generator>https://github.com/jpmonette/feed</generator>
    <icon>https://finance.naver.com/news/favicon.ico</icon>
    <entry>
        <title type="html"><![CDATA[테고사이언스, 셀라퓨틱스바이오로부터 세포치료제 CDMO 수주 [주목 e공시]]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004622292&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=406&amp;date=20211029&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004622292&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=406&amp;date=20211029&amp;page=1"/>
        <updated>2021-10-29T03:05:41.471Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004622292&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=406&amp;date=20211029&amp;page=1" title="테고사이언스, 셀라퓨틱스바이오로부터 세포치료제 CDMO 수주 [주목 e공시]">테고사이언스, 셀라퓨틱스바이오로부터 세포치료제 CDMO 수주 [주목 e공시]</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[안랩, 3분기 연결 영업이익 57억원…전년比 0.1%↓ [주목 e공시]]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004622239&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=406&amp;date=20211029&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004622239&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=406&amp;date=20211029&amp;page=1"/>
        <updated>2021-10-29T01:46:58.650Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004622239&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=406&amp;date=20211029&amp;page=1" title="안랩, 3분기 연결 영업이익 57억원…전년比 0.1%↓ [주목 e공시]">안랩, 3분기 연결 영업이익 57억원…전년比 0.1%↓ [주목 e공시]</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[SK이노, 3분기 영업이익 6천185억원…윤활유사업 역대 최대 흑자(종합)]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0012755516&amp;office_id=001&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=406&amp;date=20211029&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0012755516&amp;office_id=001&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=406&amp;date=20211029&amp;page=1"/>
        <updated>2021-10-29T01:46:58.653Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0012755516&amp;office_id=001&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=406&amp;date=20211029&amp;page=1" title="SK이노, 3분기 영업이익 6천185억원…윤활유사업 역대 최대 흑자(종합)">SK이노, 3분기 영업이익 6천185억원…윤활유사업 역대 최대 흑자(종합)</a>]]></content>
    </entry>
</feed>